🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A multicenter, randomized, double-blind, placebo-controlled, group-comparis...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00857558
Treatments Being Tested
Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Status
Unknown
Location
Kurume University Hospital
Start Date
2015-08
Trial ID
NCT02528019
Treatments Being Tested
Assessment of the effect of incretin based therapies (Liraglutide and Saxag...
Status
Completed
Location
Medical University Graz
Start Date
2012-02
Trial ID
NCT01782261
Treatments Being Tested
The purpose of this post-marketing surveillance is to investigate and confi...
Status
Completed
Location
Research Site
Start Date
2012-03-01
Trial ID
NCT01575483
Treatments Being Tested
To demonstrate bioequivalence of a 2.5 mg saxagliptin/1000 mg metformin (gl...
Status
Completed
Location
Mds Pharma Services
Start Date
2009-06
Trial ID
NCT00897390
Treatments Being Tested
SMART Study - A 24-Week, Multicenter, Randomized, Parallel-group, Open-labe...
Status
Completed
Location
Research Site
Start Date
2014-09
Trial ID
NCT02243176
Treatments Being Tested
Incretinomimetics and inhibitors of dipeptidyl peptidase-4 (DPP-4) are new ...
Status
Terminated
Location
Gastroenterology Department Erasme Hospital
Start Date
2014-10
Trial ID
NCT02244164
Treatments Being Tested
This study will evaluate the efficacy and tolerability of saxagliptin compa...
Status
Completed
Location
Research Site
Start Date
2009-10
Trial ID
NCT01006603
Treatments Being Tested
Study in healthy subjects to measure amount of drug in blood after dosing w...
Status
Completed
Location
Research Site
Start Date
2011-10
Trial ID
NCT01441869
The primary objective of this study is to assess the pharmacokinetic parame...
Status
Completed
Location
Research Site
Start Date
2013-02
Trial ID
NCT01755494